Clinical application of rapid assay of serum interleukin‐6 in Kawasaki disease
- 17 March 2008
- journal article
- research article
- Published by Wiley in Pediatrics International
- Vol. 50 (2) , 264-266
- https://doi.org/10.1111/j.1442-200x.2008.02555.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Reevaluation of the efficacy of intravenous gammaglobulin in the prevention and treatment of coronary artery lesion in Kawasaki diseaseJournal of Huazhong University of Science and Technology [Medical Sciences], 2005
- Delayed Diagnosis of Kawasaki Syndrome: An Analysis of the ProblemPediatrics, 2005
- Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropeniaEuropean Journal of Haematology, 2005
- Coronary risk factors in Kawasaki disease treated with additional gammaglobulinArchives of Disease in Childhood, 2004
- Immunoglobulin Failure and Retreatment in Kawasaki DiseasePediatric Cardiology, 2003
- The anti-inflammatory effect of methylprednisolone occurs down-stream of nuclear factor-κB DNA binding in acute pancreatitisEuropean Journal of Pharmacology, 2003
- NF-κB Activation in Peripheral Blood Monocytes/Macrophages and T Cells during Acute Kawasaki DiseaseClinical Immunology, 2001
- Intravenous gamma-globulin treatment and retreatment in Kawasaki diseaseThe Pediatric Infectious Disease Journal, 1998
- Cytokines predict coronary aneurysm formation in Kawasaki disease patientsEuropean Journal of Pediatrics, 1993
- Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki diseaseThe Journal of Pediatrics, 1992